Impact of Modifying Lazertinib Doses on Effectiveness and Safety in Patients With <scp>EGFR</scp>‐Positive Advanced Lung Cancer: A Multicenter, Prospective Observational Cohort Study
- DOI
- 10.1111/1759-7714.70083
- Published
- 2025-05
- Container
- Thoracic Cancer
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/1759-7714.70083,
title = {Impact of Modifying Lazertinib Doses on Effectiveness and Safety in Patients With <scp>EGFR</scp>‐Positive Advanced Lung Cancer: A Multicenter, Prospective Observational Cohort Study},
author = {Mi‐Hyun Kim and Min Ki Lee and Ji Eun Park and Sun Hyo Park and Tae Won Jang and Chi Young Jung and Insu Kim and Seong Hoon Yoon and June Hong Ahn and Hyun‐Kyung Lee and Jin Han Park and Sun Ha Choi and Jung Seop Eom},
year = {2025},
journal = {Thoracic Cancer},
doi = {10.1111/1759-7714.70083},
url = {https://doi.org/10.1111/1759-7714.70083}
}RIS
TY - JOUR TI - Impact of Modifying Lazertinib Doses on Effectiveness and Safety in Patients With <scp>EGFR</scp>‐Positive Advanced Lung Cancer: A Multicenter, Prospective Observational Cohort Study AU - Mi‐Hyun Kim AU - Min Ki Lee AU - Ji Eun Park AU - Sun Hyo Park AU - Tae Won Jang AU - Chi Young Jung AU - Insu Kim AU - Seong Hoon Yoon AU - June Hong Ahn AU - Hyun‐Kyung Lee AU - Jin Han Park AU - Sun Ha Choi AU - Jung Seop Eom PY - 2025 JO - Thoracic Cancer DO - 10.1111/1759-7714.70083 UR - https://doi.org/10.1111/1759-7714.70083 ER -
APA
Kim, M., Lee, M. K., Park, J. E., Park, S. H., Jang, T. W., Jung, C. Y., Kim, I., Yoon, S. H., Ahn, J. H., Lee, H., Park, J. H., Choi, S. H., & Eom, J. S. (2025). Impact of Modifying Lazertinib Doses on Effectiveness and Safety in Patients With <scp>EGFR</scp>‐Positive Advanced Lung Cancer: A Multicenter, Prospective Observational Cohort Study. Thoracic Cancer. https://doi.org/10.1111/1759-7714.70083
Source records
- crossref · retrieved 2026-09-25T00:18:47.632Z